Eugene Schneider, EVP, Chf Clinical Develop Ofcr at IONIS PHARMACEUTICALS INC (IONS), sold 26,000 shares at $81.05 ($2.1M) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($2.1M) by EVP, Chf Clinical Develop Ofcr under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IONS | SELL | 2026-01-20 | $703K | — | Filing → |
| IONS | SELL | 2025-09-04 | $2.4M | — | Filing → |
| IONS | SELL | 2025-08-05 | $817K | — | Filing → |